These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24266897)

  • 1. BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.
    Bari MF; Brown H; Nicholson AG; Kerr KM; Gosney JR; Wallace WA; Soomro I; Muller S; Peat D; Moore JD; Ward LA; Freidin MB; Lim E; Vatish M; Snead DR
    Histopathology; 2014 Mar; 64(4):547-56. PubMed ID: 24266897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.
    Jones MH; Virtanen C; Honjoh D; Miyoshi T; Satoh Y; Okumura S; Nakagawa K; Nomura H; Ishikawa Y
    Lancet; 2004 Mar; 363(9411):775-81. PubMed ID: 15016488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
    Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
    J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of differentially expressed genes in neuroendocrine carcinomas of the lung.
    Okubo C; Minami Y; Tanaka R; Uchihara T; Anami Y; Furuya S; Morishita Y; Iijima T; Noguchi M
    J Thorac Oncol; 2006 Oct; 1(8):780-6. PubMed ID: 17409960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
    Dong S; Liang J; Zhai W; Yu Z
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall.
    Inoue H; Matsushima J; Kobayashi S; Sairenchi T; Hirata H; Chida M; Ota S; Ban S; Matsumura Y
    Int J Surg Pathol; 2022 Apr; 30(2):151-159. PubMed ID: 34913369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.
    Nitadori J; Ishii G; Tsuta K; Yokose T; Murata Y; Kodama T; Nagai K; Kato H; Ochiai A
    Am J Clin Pathol; 2006 May; 125(5):682-92. PubMed ID: 16707368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.
    Lee H; Fu Z; Koo BH; Sheehan CE; Young GQ; Lin J; Patil DT; Yang Z
    Ann Diagn Pathol; 2018 Dec; 37():30-34. PubMed ID: 30236546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
    Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M
    Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
    Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
    Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.
    Zhou Z; Zhu L; Niu X; Shen S; Zhao Y; Zhang J; Ye J; Han-Zhang H; Liu J; Liu C; Lu S
    Thorac Cancer; 2019 Apr; 10(4):839-847. PubMed ID: 30793508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
    Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
    Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
    Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
    Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
    Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
    J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
    Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H
    Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.